Translational stem cell therapy for amyotrophic lateral sclerosis

被引：0
|
作者：
Nicholas M. Boulis
Thais Federici
Jonathan D. Glass
J. Simon Lunn
Stacey A. Sakowski
Eva L. Feldman
机构：
[1] Emory University,Department of Neurosurgery
[2] Emory University,Department of Neurology
[3] University of Michigan,Department of Neurology
来源：
Nature Reviews Neurology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The first-in-human phase I trial of stem cell transplantation for amyotrophic lateral sclerosis was approved by the FDA in 2009 and is ongoing. In their Perspectives article, Eva Feldman and colleagues, who are conducting the trial, discuss the preclinical research supporting this therapeutic approach, key aspects of the trial design to overcome translational issues, and ongoing challenges to address in future studies.
引用
收藏
页码：172 / 176
页数：4
相关论文
共 50 条
  • [41] The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus
    Yu. N. Rushkevich
    S. M. Kosmacheva
    G. V. Zabrodets
    S. I. Ignatenko
    N. V. Goncharova
    I. N. Severin
    S. A. Likhachev
    M. P. Potapnev
    Bulletin of Experimental Biology and Medicine, 2015, 159 : 576 - 581
  • [42] The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus
    Rushkevich, Yu. N.
    Kosmacheva, S. M.
    Zabrodets, G. V.
    Ignatenko, S. I.
    Goncharova, N. V.
    Severin, I. N.
    Likhachev, S. A.
    Potapnev, M. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 159 (04) : 576 - 581
  • [43] Stem Cells for Amyotrophic Lateral Sclerosis Modeling and Therapy: Myth or Fact?
    Coatti, G. C.
    Beccari, M. S.
    Olavio, T. R.
    Mitne-Neto, M.
    Okamoto, O. K.
    Zatz, M.
    CYTOMETRY PART A, 2015, 87A (03) : 197 - 211
  • [44] Editorial: Translational study for amyotrophic lateral sclerosis treatment
    Schroeder, Sven
    Litscher, Gerhard
    Pan, Weidong
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [45] Translational Therapeutic Str ategies in Amyotrophic Lateral Sclerosis
    Ryu, Hoon
    Ferrante, Robert J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 141 - 150
  • [46] Cell therapy in amyotrophic lateral sclerosis: A significant step forward
    Ben-Hur, Tamir
    ANNALS OF NEUROLOGY, 2014, 75 (03) : 337 - 338
  • [47] Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis
    Sirbulescu, Ruxandra F.
    Nicholson, Katharine
    Kawai, Kento
    Hilton, Orla M.
    Sobell, Don
    Jin, Gina
    Verrill, David E.
    Dwyer, Liam J.
    Xiong, Yueyue
    Bachanova, Petra
    Kim, Spencer E.
    Gallup, Shannon
    Gelevski, Dario
    Daley, Heather
    Hernandez Rodriguez, Diego E.
    Negre, Helene
    Sturtevant, Olive
    Nikiforow, Sarah
    Ritz, Jerome
    Chen, Yi-Bin
    Reeves, Patrick M.
    Sluder, Ann E.
    Berry, James D.
    Sadri-Vakili, Ghazaleh
    Cudkowicz, Merit
    Poznansky, Mark C.
    FASEB JOURNAL, 2024, 38 (13):
  • [48] Gene Therapy in Amyotrophic Lateral Sclerosis
    Fang, Ton
    Je, Goun
    Pacut, Peter
    Keyhanian, Kiandokht
    Gao, Jeff
    Ghasemi, Mehdi
    CELLS, 2022, 11 (13)
  • [49] Drug Therapy in Amyotrophic Lateral Sclerosis
    Distad, B. Jane
    Meekins, Gregg D.
    Liou, Lee L.
    Weiss, Michael D.
    Carter, Gregory T.
    Miller, Robert G.
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2008, 19 (03) : 633 - +
  • [50] Amyotrophic lateral sclerosis and gene therapy
    Timothy M Miller
    Richard A Smith
    Don W Cleveland
    Nature Clinical Practice Neurology, 2006, 2 : 462 - 463
12345